Early Intervention in High Risk CCUS
Early Intervention in High Risk CCUS
Recruiting · NCT06802146 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Intervention in High Risk CCUS | Cytopenia, Hemic and Lymphatic Diseases, hematologic disorder | Recruiting | Early phase 1 | 2026-04-23 | NCT06802146 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astex Pharmaceuticals, Inc. | 12 |
| Break Through Cancer | 1 |
| Lachelle D. Weeks, MD, PhD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |